News for AspenBio Pharma, Inc. - Google FinanceNews for AspenBio Pharma, Inc. - Google FinancePatient Enrollment for AspenBio Pharma's FDA 510(k) Clinical Trial for AppyScoreTM, World's First Ap- September 7, 2008 Patient Enrollment for AspenBio Pharma's FDA 510(k) Clinical Trial for AppyScoreTM, World's First Ap PR-USA.net (press release) - Sep 7, 2008 AspenBio Pharma , Inc . ( NASDAQ : APPY ) an emerging bio - pharmaceutical company dedicated to the development of novel drugs and diagnostics for humans and animals , reported enrollment levels ...http://pr-usa.net/index.php?option=com_content&task=view&id=130675&Itemid=30 Patient Enrollment for AspenBio Pharma's FDA 510(k) Clinical Trial for AppyScore(TM), World's First Appendicitis Blood Test, Nearing Halfway Point- September 4, 2008 Patient Enrollment for AspenBio Pharma's FDA 510(k) Clinical Trial for AppyScore(TM), World's First Appendicitis Blood Test, Nearing Halfway Point CNNMoney.com - Sep 4, 2008 AspenBio Pharma , Inc . ( NASDAQ : APPY ) an emerging bio - pharmaceutical company dedicated to the development of novel drugs and diagnostics for humans and animals , reported enrollment levels ...http://money.cnn.com/news/newsfeeds/articles/marketwire/0430781.htm |